Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.61 USD | +3.54% | +20.22% | +67.25% |
19/03 | North American Morning Briefing : Stock Futures -2- | DJ |
14/03 | Larimar Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on Larimar Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Larimar Therapeutics, Inc.
Guggenheim | |
Citigroup | |
JMP Securities | |
William Blair & Co. |
EPS Revisions
- Stock Market
- Equities
- LRMR Stock
- Consensus Larimar Therapeutics, Inc.